Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00100750 | Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 31 | National Cancer Institute (NCI)NIH | 1 | Jan 13, 2015 | clinicaltrials |
| NCT01858116 | PET Study of Breast Cancer Patients Using [68Ga]ABY-025 | completed | Phase 1 / Phase 2 | 16 | Biomedical Radiation SciencesOTHER | 1 | Jan 13, 2015 | clinicaltrials |
| NCT00199134 |
| FRAGRANCE Part A Safety: Study to Find a Genetic Signature of de Novo Resistance to Letrozole |
| completed |
| Phase 2 |
| 49 |
| Jules Bordet InstituteOTHER |
| 1 |
| Jan 6, 2015 |
| clinicaltrials |
| NCT00044525 | Evaluation of BAY59-8862 in Taxane-Resistant Metastatic Breast Cancer Patients | completed | Phase 2 | 82 | BayerINDUSTRY | 7 | Dec 23, 2014 | clinicaltrials |
| NCT00821886 | Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer | completed | Phase 2 | 60 | SCRI Development Innovations, LLCOTHER | 1 | Dec 22, 2014 | clinicaltrials |
| NCT00825734 | Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 83 | SCRI Development Innovations, LLCOTHER | 1 | Dec 22, 2014 | clinicaltrials |
| NCT00915603 | Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer | completed | Phase 2 | 113 | SCRI Development Innovations, LLCOTHER | 1 | Dec 22, 2014 | clinicaltrials |
| NCT01286168 | Trial of Drain Antisepsis After Tissue Expander Breast Reconstruction | completed | Phase 2 | 110 | Mayo ClinicOTHER | 1 | Dec 19, 2014 | clinicaltrials |
| NCT00751868 | FEC With G-CSF Support Followed by Ixabepilone With G-CSF Support as Neoadjuvant Chemotherapy in BC(GIM9) | completed | Phase 2 | 47 | Consorzio OncotechOTHER | 1 | Dec 17, 2014 | clinicaltrials |
| NCT01262469 | Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer.(GERICO09) | completed | Phase 2 | 4 | UNICANCEROTHER | 1 | Dec 16, 2014 | clinicaltrials |
| NCT00256360 | Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer | completed | Phase 2 | 117 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Dec 9, 2014 | clinicaltrials |
| NCT00284336 | Caelyx Adjuvant in Elderly Breast Cancer | completed | Phase 2 | 16 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Dec 9, 2014 | clinicaltrials |
| NCT00288249 | Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer | completed | Phase 2 | 82 | BayerINDUSTRY | 10 | Dec 2, 2014 | clinicaltrials |
| NCT00376909 | A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women | completed | Phase 2 | 2,729 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT02001519 | Additional 4 Cycles of Cisplatin (CDDP4) in Patients With Triple Negative Breast Cancer for Neoadjuvant Chemotherapy(PACER) | completed | Phase 2 | 88 | Asan Medical CenterOTHER | 1 | Dec 2, 2014 | clinicaltrials |
| NCT00365599 | Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer | completed | Phase 2 | 43 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 21, 2014 | clinicaltrials |
| NCT00559754 | A Study of Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer. | completed | Phase 2 | 72 | Hoffmann-La RocheINDUSTRY | 1 | Nov 10, 2014 | clinicaltrials |
| NCT01969032 | Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast Cancer | completed | Phase 2 | 41 | Russian Academy of Medical SciencesOTHER | 1 | Nov 5, 2014 | clinicaltrials |
| NCT00068588 | GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 24 | National Cancer Institute (NCI)NIH | 1 | Oct 31, 2014 | clinicaltrials |
| NCT00960336 | Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast Cancer | completed | Phase 2 | 59 | ARCAGY/ GINECO GROUPOTHER | 1 | Oct 29, 2014 | clinicaltrials |
| NCT01434134 | Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy(PRADA) | completed | Phase 2 | 130 | University Hospital, AkershusOTHER | 1 | Oct 22, 2014 | clinicaltrials |
| NCT01993576 | ICG Distribution Using NIF Imaging After IV Injection of ICG in Benign and Malignant Breast Cancer Tissue.(EC2075) | completed | Phase 1 / Phase 2 | 10 | Jules Bordet InstituteOTHER | 1 | Oct 15, 2014 | clinicaltrials |
| NCT00924352 | Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 56 | Accelerated Community Oncology Research NetworkOTHER | 1 | Oct 13, 2014 | clinicaltrials |
| NCT00555919 | ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer | completed | Phase 2 | 68 | BayerINDUSTRY | 10 | Oct 10, 2014 | clinicaltrials |
| NCT01196052 | A Study of Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast Cancer | completed | Phase 2 | 153 | Hoffmann-La RocheINDUSTRY | 8 | Oct 6, 2014 | clinicaltrials |
| NCT00134680 | Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC | completed | Phase 2 | 33 | Duke UniversityOTHER | 1 | Sep 16, 2014 | clinicaltrials |
| NCT00475670 | A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer | completed | Phase 2 | 44 | Hoffmann-La RocheINDUSTRY | 15 | Sep 15, 2014 | clinicaltrials |
| NCT00919880 | Comparison of Neo-adjuvant Weekly Paclitaxel With or Without Carboplatin in Early Breast Cancer | completed | Phase 2 | 148 | Tao OUYANGOTHER | 1 | Aug 15, 2014 | clinicaltrials |
| NCT00846027 | A Study of Avastin (Bevacizumab) in Combination With Taxane-based Chemotherapy as First Line Treatment in Patients With HER-2 Negative Breast Cancer | completed | Phase 2 | 90 | Hoffmann-La RocheINDUSTRY | 1 | Jul 23, 2014 | clinicaltrials |
| NCT00077025 | Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer | completed | Phase 2 | 174 | AstraZenecaINDUSTRY | 4 | Jul 16, 2014 | clinicaltrials |
| NCT00179309 | Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer | completed | Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jul 15, 2014 | clinicaltrials |
| NCT02115984 | Study of the Safety and Leukostimulatory Activity of the Preparation "Panagen" in Patients With Breast Cancer | completed | Phase 2 | 80 | Panagen, Limited Liability CompanyOTHER | 0 | Jul 15, 2014 | clinicaltrials |
| NCT00246090 | A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine | completed | Phase 2 | 298 | Eisai Inc.INDUSTRY | 2 | Jul 14, 2014 | clinicaltrials |
| NCT02005549 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer | completed | Phase 2 | 18 | Hoffmann-La RocheINDUSTRY | 1 | Jul 14, 2014 | clinicaltrials |
| NCT00405678 | Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy. | completed | Phase 1 / Phase 2 | 23 | Duke UniversityOTHER | 1 | Jul 11, 2014 | clinicaltrials |
| NCT01266486 | Effect of Metformin on Breast Cancer Metabolism | completed | Phase 2 | 41 | Oxford University Hospitals NHS TrustOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT01070485 | BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant Disease | completed | Phase 2 | 23 | BayerINDUSTRY | 3 | Jun 25, 2014 | clinicaltrials |
| NCT01500577 | A Prevention Trial in Subjects at High Risk for Breast Cancer | completed | Phase 2 | 150 | European Institute of OncologyOTHER | 1 | Jun 18, 2014 | clinicaltrials |
| NCT02005926 | The Accuracy of Sentinel Node Biopsy of Breast Cancer With Sonographic Abnormal Axillary Lymph Nodes | completed | Phase 2 | 200 | Tao OUYANGOTHER | 1 | Jun 18, 2014 | clinicaltrials |
| NCT01163552 | Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity | completed | Phase 2 | 5 | St. Luke's-Roosevelt Hospital CenterOTHER | 1 | Jun 13, 2014 | clinicaltrials |
| NCT00087152 | S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer | completed | Phase 2 | 27 | National Cancer Institute (NCI)NIH | 0 | Jun 9, 2014 | clinicaltrials |
| NCT00918281 | Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection | completed | Phase 2 | 70 | GE HealthcareINDUSTRY | 1 | Jun 9, 2014 | clinicaltrials |
| NCT00198237 | Genomic & Proteomic Analysis of Docetaxel & Capecitabine as Primary Chemo for Stage II-III Breast Cancer | completed | Phase 2 | 40 | Indiana UniversityOTHER | 1 | Jun 3, 2014 | clinicaltrials |
| NCT00258349 | Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer | completed | Phase 1 / Phase 2 | 16 | National Cancer Institute (NCI)NIH | 1 | Jun 2, 2014 | clinicaltrials |
| NCT01142479 | Compound Herbal Formula (TPE-1) for Leukopenia and Cancer-related Fatigue in Breast Cancer Patients With Radiotherapy | completed | Phase 2 / Phase 3 | 60 | Taipei City HospitalOTHER_GOV | 1 | May 29, 2014 | clinicaltrials |
| NCT00217399 | Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 35 | National Cancer Institute (NCI)NIH | 1 | May 28, 2014 | clinicaltrials |
| NCT00004888 | Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 84 | National Cancer Institute (NCI)NIH | 1 | May 23, 2014 | clinicaltrials |
| NCT00003050 | Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer | completed | Phase 2 | 46 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00077376 | Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer | completed | Phase 2 | 61 | National Cancer Institute (NCI)NIH | 1 | May 21, 2014 | clinicaltrials |
| NCT00493636 | 1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy | completed | Phase 2 | 160 | Accelerated Community Oncology Research NetworkOTHER | 1 | May 20, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Jan 13, 2015source: clinicaltrials